4-thio-2-deoxycytidine
Term · Oncology and biomedicine · MLC-T-ONC-009545
An orally bioavailable 4-thio modified 2-deoxycytidine analog, with potential antineoplastic activity. Upon administration of 4-thio-2-deoxycytidine (TdCyd), this cytidine analog gets incorporated into DNA during replication and inhibits the activity of DNA methyltransferase 1 (DNMT1), which blocks DNA hypermethylation. This results in DNMT1 depletion, hypomethylation of DNA, and the reactivation of tumor suppressor genes that were silenced by hypermethylation; this results in antitumor activity and an inhibition of tumor cell proliferation.
| Identifier | MLC-T-ONC-009545 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | TdCyd |
| Synonyms | 4'-thio-2'-deoxycytidine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009545",
"term": "4-thio-2-deoxycytidine",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable 4-thio modified 2-deoxycytidine analog, with potential antineoplastic activity. Upon administration of 4-thio-2-deoxycytidine (TdCyd), this cytidine analog gets incorporated into DNA during replication and inhibits the activity of DNA methyltransferase 1 (DNMT1), which blocks DNA hypermethylation. This results in DNMT1 depletion, hypomethylation of DNA, and the reactivation of tumor suppressor genes that were silenced by hypermethylation; this results in antitumor activity and an inhibition of tumor cell proliferation.",
"abbreviation": "TdCyd",
"synonyms": [
"4'-thio-2'-deoxycytidine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/4-thio-2-deoxycytidine/"
}
Record 96 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.